系统性红斑狼疮误诊原因探讨

系统性红斑狼疮(SLE)表现为多系统损害。由于首发症状不尽相同,极易延误诊断,误诊率可高达31.5～51.2％。笔者随机抽取1979～1986年收治的63例,发现其中的36例曾延误诊断,现将误诊的原因分析探讨如下。     

儿童系统性红斑狼疮误诊为病毒性脑炎二例

【例1】女,12岁。因反复发热伴头痛、头晕及恶心1月余入院。患儿1月前受凉后出现发热、头痛、头晕及恶心,外院诊断为病毒性脑炎,予降颅压、抗病毒及清热解毒等治疗17d,症状缓解出院。出院7d后患儿头痛加剧,并出现短暂性意识模糊,持续时间约10min,可自行缓解,缓解后乏力、嗜睡,遂入我院。查体：体温40℃,     

系统性红斑狼疮1例多次误诊分析

患者，女，34岁，2003年1月出现手指小关节疼痛，在当地县医院诊断为类风湿性关节炎。给予“强的松”20mg，1次，d口服，疼痛有所缓解。2004年1月出现刺激性干咳，午后高热T38～40℃，在当地县医院诊断为“结核性胸膜炎”；查乙肝五项及肝功能正常，予以“雷米封、利福平、链霉素、氟美松(30mg/d，用4d后减5mg／d，6d后停用)”治疗，共住院10d后自动出院，出院后     

系统性红斑狼疮12例误诊分析

系统性红斑狼疮 (SLE)是一种好发于女性、并有多器官系统损害的疾病 ,常有皮肤、肾脏、关节、血液、神经系统的损害 ,血液中可能有多种自身抗体出现。参照美国风湿病协会 1982年制定的诊断标准 ,典型的SLE不难诊断 ,但一些SLE早期很不典型 ,常被误诊为其他疾病 ,笔者近年诊治过误诊的 12例患者 ,现报告如下 ,以期引起同行的重视 ,提高诊断的准确率。1　临床资料1.1　一般资料　本组 12例 ,女性 11例 ,男性 1例 ,年龄 19～4 5岁 ,误诊时间 3个月至 10年。1.2　临床表现　发病初 2例表现为皮肤紫癜、血小板减少 ,2例表现为发热伴皮疹 ,2例…     

系统性红斑狼疮误诊23例分析

对我院1997年以来系统性红斑狼疮（SLE）误诊23例分析如下。     

系统性红斑狼疮61例误诊分析

系统性红斑狼疮６１例误诊分析石家庄市白求恩国际和平医院［０５００８２］惠乃玲，于有山，康尔竹，张志贵系统性红斑狼疮（ＳＬＥ）是一种全身多系统的慢性非化脓性炎性疾病，累及全身结缔组织，呈现多脏器损害，临床表现复杂，变化多样，多见于青春期和生育期女性。我...     

系统性红斑狼疮1例误诊的教训

患者,女,43岁。因少尿、浮肿4个月,咳嗽、发热15天于1991年11月30日入院。4个月前上呼吸道感染,1周后出现少尿,每日尿量400ml左右,伴颜面及下肢浮肿,腰痛乏力,经当地医院中药治疗,症状无明显好转,15天前出现咳嗽,发热,心悸,气     

浅析系统性红斑狼疮的误诊

系统性红斑狼疮(SLE)系自身免疫性疾病,以多系统脏器损害和多种自身抗体出现为其特点,临床表现复杂多样,易误诊。现就我们遇到的误诊病例中列举5例典型误诊病例加以分析,希望从中得到某些启示。 1 临床资料 例1,女,51岁。主诉浮肿3月,少尿3天。既往有腕关节疼痛史。查:T37.5℃,BP29/15kPa,贫血貌,颜面、下肢肿,无皮疹,右肺闻湿罗音,心界大,     

系统性红斑狼疮误诊分析

系统性红斑狼疮(SLE)是一种典型的自身免疫病，病期长期反复并伴有全身多器官、系统受累的慢性病。近年来，SLE的发病率有升高趋势，并且临床表现复杂、多样，可以某一器官损害为主或以并发症为首发表现，尤其是早期临床症状较轻者，如医生对本病缺乏认识易导致误诊、漏诊现象。     

Systemic lupus erythematosus

Systemic lupus erythematosus is a multisystem inflammatory disease characterized by autoantibody production. Recent investigations are providing insights into the immunoregulatory disturbances underlying this disease, and are clarifying the approach to diagnosis and treatment.     

Systemic lupus erythematosus

Given its diverse manifestations, systemic lupus erythematosus is a thorny therapeutic problem. Given the increase in prevalence, coming to grips with the controversial issues of when to treat and what treatment to use is paramount. In this article, Dr Ballou offers a consensus opinion on management based on a review of the recent medical literature.     

Systemic lupus erythematosus

Systemic lupus erythematosus (SLE) is a complex multisystem autoimmune disease of unknown aetiology that is subject to period of exacerbation and remission. Treatments aimed at controlling disease activity remain primarily by immunosuppression, the prescribing of which is dependent on the development of any multisystem complications. With the establishment of dedicated lupus clinics using a multidisciplinary team approach, prognosis is better and treatment options continue to improve.     

Systemic lupus erythematosus

Summary The reported change in the incidence of systemic lupus erythematosus (SLE) is mainly due to a greater awareness of the disease, and to the introduction of serological detection methods such as the LE cell assay and subsequently a variety of other antinuclear antibody assays. SLE is seldom preceded by rheumatoid arthritis, nor does SLE often develop in patients with rheumatoid arthritis. In a substantial proportion of our SLE patients, discoid LE occurred first. On analyzing the literature no evidence could be found that nowadays less severe SLE is diagnosed. Also, in the last three decades no change has been observed in the prevalence of clinical features in large groups of patients with SLE. These data indicate that there has been no change in the expression or prognosis of SLE in recent decades.     

Systemic lupus erythematosus.

Systemic lupus erythematosus is a challenging diagnosis. This article provides an overview of this disorder and what nurses need to know to provide care to patients with this potentially life-threatening disorder.